tweetindex

Gregg Fonarow MD

@gcfmd · Los Angeles, CA · joined 25 Dec 2012

12 442Followers
178Following
11 788Posts total
24.3KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. shown far beyond its own audience, and the audience reacts.

Median views1 968this account3 137median for 10K–100K
Reach, %15.82%this account10.26%median for 10K–100K
Engagement, %2.26%this account1.47%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post1 9683 1370.63×
Reach (views ÷ followers)15.82%10.26%1.54×
Engagement rate2.26%1.47%1.54×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.9K1 Sep
17.3K2 Sep
1.2K
931
2K3 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

2.26%1 Sep
1.77%2 Sep
1.76%
2.36%
2.29%3 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.47%.

What the audience does

Likes56.7%346 in total
Reposts15.9%97 in total
Replies2.1%13 in total
Quotes0.8%5 in total
Bookmarks24.4%149 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

📉💊❤️ Statins for primary prevention = fewer deaths USPSTF meta-analyses: 
2016: HR 0.86 ✅
2022: HR 0.92 ✅ 4 landmark RCTs (JUPITER, HOPE-3, AFCAPS, STAREE) pooled: ☠️ HR 0.90 (0.83–0.98) ✅ 🟢 benefit is real, but modest
 ⚖️ net benefits >> potential risks https://t.co/4m 2K views · 36 likes · 8 reposts · 1 replies 03 Sep 2026 🫀Hospitals joining Get With The Guidelines–Heart Failure saw gains in guideline-directed medications for HFrEF ⤴️ β-blockers, RASI & MRAs 💊📈 Post-discharge mortality lower QI programs can make a difference! 🏥✅ #CardioTwitter https://t.co/NPBuHQOHzq https://t.co/DG2raa 931 views · 15 likes · 7 reposts · 0 replies 02 Sep 2026 Get With The Guidelines–Heart Failure Hospital Participation and Its Association With Guideline-Directed Medical Therapy and Outcomes | Circulation: Heart Failure https://t.co/BRA5aOPkIg @ATSandhu @paheidenreich @CircHF @AHAScience @AHA_Research @NMHheartdoc @docsabe 1.2K views · 15 likes · 6 reposts · 0 replies 02 Sep 2026 🫀 Statins for primary prevention: 4 RCTs, 3 decades AFCAPS→JUPITER→HOPE-3→STAREE 📉 24–44% ↓ major CV events Even at baseline LDL (108 mg/dL) No heterogeneity across subgroups in RRR 
🟰 Safety ≈ placebo, few exceptions 
⚖️ Benefits ≫ risks 💊 cost $30/year https://t.co/cFVgoF 17.3K views · 228 likes · 66 reposts · 10 replies 02 Sep 2026 💊 Sacubitril/valsartan in HFrEF ❤️ ↓20% CV ☠️ & HF 🏨 vs enalapril ⬇️ all-cause ☠️ ↓16% 🛟 1-2 year extension of median survival 🏥 Fewer HF 🏨 ↓21% 😌 Better symptoms & quality of life 🥇 A cornerstone of GDMT 🥳 Now only $12.25/month ($147/year) 97/103 mg twice a day http 2.9K views · 52 likes · 10 reposts · 2 replies 01 Sep 2026

Similar accounts